Farxiga and Thrombocytopenia - a phase IV clinical study of FDA data

Summary:

Thrombocytopenia is reported as a side effect among people who take Farxiga (dapagliflozin), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Metformin, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Thrombocytopenia when taking Farxiga. It is created by eHealthMe based on reports of 18,416 people who have side effects when taking Farxiga from the FDA, and is updated regularly.

What is Farxiga?

Farxiga has active ingredients of dapagliflozin. It is often used in diabetes. eHealthMe is studying from 18,798 Farxiga users. Check the latest studies of Farxiga.

What is Thrombocytopenia?

Thrombocytopenia (decrease of platelets in blood) is found to be associated with 2,794 drugs and 4,868 conditions by eHealthMe. Check the latest studies of Thrombocytopenia.

On Jul, 03, 2026

18,416 people reported to have side effects when taking Farxiga.
Among them, 38 people (0.21%) have Thrombocytopenia.

Among these 38 people:

How long have people been on Farxiga when they have Thrombocytopenia? *

What is the gender of people who have Thrombocytopenia when taking Farxiga? *

female: 51.52 %
male: 48.48 %

What is the age of people who have Thrombocytopenia when taking Farxiga? *

What are other drugs people take besides Farxiga? *

What are other side effects people have besides Thrombocytopenia? *

White Blood Cell Count Decreased: 8 people, 21.05%
Nausea (feeling of having an urge to vomit): 7 people, 18.42%
Fatigue (feeling of tiredness): 7 people, 18.42%
Weakness: 5 people, 13.16%
Anaemia (lack of blood): 5 people, 13.16%
Nausea And Vomiting: 4 people, 10.53%
Fall: 4 people, 10.53%
The Flu (the flu is caused by an influenza virus): 4 people, 10.53%
Rashes (redness): 4 people, 10.53%
High Blood Pressure: 4 people, 10.53%

What are the existing conditions these people have? *

Type 2 Diabetes: 8 people, 21.05%
Ovarian Cancer (cancer of ovary): 4 people, 10.53%
High Blood Cholesterol: 4 people, 10.53%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 10.53%
Multiple Myeloma (cancer of the plasma cells): 3 people, 7.89%
Thyroid Diseases: 3 people, 7.89%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 7.89%
Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 1 person, 2.63%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 2.63%
Asthma: 1 person, 2.63%

* Approximation only. Some reports may have incomplete information.

Do you take Farxiga and have Thrombocytopenia?

- Check whether Thrombocytopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Farxiga:

Farxiga (18,798 reports)

Thrombocytopenia treatments and more:

Thrombocytopenia (285,083 reports)

Browse all side effects of Farxiga:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thrombocytopenia:

Thrombocytopenia (2,794 drugs)

Browse all the conditions that are associated with Thrombocytopenia:

Thrombocytopenia (4,868 conditions)

Related publications that referenced our studies

YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .
YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on dapagliflozin (the active ingredients of Farxiga) and Farxiga (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.